Trexquant Investment LP Has $1.19 Million Holdings in Indivior PLC (NASDAQ:INDV)

Trexquant Investment LP reduced its stake in Indivior PLC (NASDAQ:INDV - Free Report) by 44.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 95,893 shares of the company's stock after selling 75,521 shares during the quarter. Trexquant Investment LP owned about 0.07% of Indivior worth $1,192,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. acquired a new position in Indivior during the fourth quarter worth approximately $56,000. Stifel Financial Corp purchased a new stake in shares of Indivior during the third quarter valued at approximately $100,000. Jane Street Group LLC acquired a new stake in shares of Indivior during the third quarter valued at about $180,000. China Universal Asset Management Co. Ltd. purchased a new position in Indivior in the fourth quarter valued at about $359,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in Indivior during the 3rd quarter valued at approximately $294,000. 60.33% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. RODMAN&RENSHAW raised Indivior to a "strong-buy" rating in a report on Tuesday, January 28th. Rodman & Renshaw started coverage on Indivior in a research note on Tuesday, January 28th. They issued a "buy" rating and a $16.00 target price for the company. Finally, Piper Sandler cut their price target on Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a report on Thursday, March 6th.

Remove Ads

Indivior Stock Performance

Shares of NASDAQ:INDV traded down $0.03 during midday trading on Wednesday, reaching $9.08. The company had a trading volume of 108,982 shares, compared to its average volume of 929,872. The company has a fifty day simple moving average of $9.54 and a two-hundred day simple moving average of $10.34. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of -25.97 and a beta of 0.93. Indivior PLC has a 1-year low of $7.33 and a 1-year high of $19.78.

Indivior (NASDAQ:INDV - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.32. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The company had revenue of $298.00 million during the quarter, compared to analyst estimates of $262.35 million. Analysts expect that Indivior PLC will post 1.22 EPS for the current year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.